244 related articles for article (PubMed ID: 16015668)
1. Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure.
Zhu Y; Shi J; Shen W; Dong X; Feng J; Ruan M; Li Y
Angew Chem Int Ed Engl; 2005 Aug; 44(32):5083-7. PubMed ID: 16015668
[No Abstract] [Full Text] [Related]
2. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles.
Giri S; Trewyn BG; Stellmaker MP; Lin VS
Angew Chem Int Ed Engl; 2005 Aug; 44(32):5038-44. PubMed ID: 16038000
[No Abstract] [Full Text] [Related]
3. Controlled release of avermectin from porous hollow silica nanoparticles: influence of shell thickness on loading efficiency, UV-shielding property and release.
Li ZZ; Xu SA; Wen LX; Liu F; Liu AQ; Wang Q; Sun HY; Yu W; Chen JF
J Control Release; 2006 Mar; 111(1-2):81-8. PubMed ID: 16388871
[TBL] [Abstract][Full Text] [Related]
4. Stimuli-free auto-modulated material release from mesoporous nanocompartment films.
Ji Q; Miyahara M; Hill JP; Acharya S; Vinu A; Yoon SB; Yu JS; Sakamoto K; Ariga K
J Am Chem Soc; 2008 Feb; 130(8):2376-7. PubMed ID: 18251466
[No Abstract] [Full Text] [Related]
5. Fabrication of uniform magnetic nanocomposite spheres with a magnetic core/mesoporous silica shell structure.
Zhao W; Gu J; Zhang L; Chen H; Shi J
J Am Chem Soc; 2005 Jun; 127(25):8916-7. PubMed ID: 15969545
[TBL] [Abstract][Full Text] [Related]
6. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
[TBL] [Abstract][Full Text] [Related]
7. Potential of amorphous microporous silica for ibuprofen controlled release.
Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA
Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of well-dispersed layered double hydroxide core@ordered mesoporous silica shell nanostructure (LDH@mSiO₂) and its application in drug delivery.
Bao H; Yang J; Huang Y; Xu ZP; Hao N; Wu Z; Lu GQ; Zhao D
Nanoscale; 2011 Oct; 3(10):4069-73. PubMed ID: 21858347
[TBL] [Abstract][Full Text] [Related]
9. Enantioselectively controlled release of chiral drug (metoprolol) using chiral mesoporous silica materials.
Guo Z; Du Y; Liu X; Ng SC; Chen Y; Yang Y
Nanotechnology; 2010 Apr; 21(16):165103. PubMed ID: 20351409
[TBL] [Abstract][Full Text] [Related]
10. pH-disintegrable polyelectrolyte multilayer-coated mesoporous silica nanoparticles exhibiting triggered co-release of cisplatin and model drug molecules.
Wan X; Zhang G; Liu S
Macromol Rapid Commun; 2011 Jul; 32(14):1082-9. PubMed ID: 21618323
[TBL] [Abstract][Full Text] [Related]
11. pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker.
Liu R; Zhang Y; Zhao X; Agarwal A; Mueller LJ; Feng P
J Am Chem Soc; 2010 Feb; 132(5):1500-1. PubMed ID: 20085351
[TBL] [Abstract][Full Text] [Related]
12. NIR-enhanced drug release from porous Au/SiO2 nanoparticles.
Yagüe C; Arruebo M; Santamaria J
Chem Commun (Camb); 2010 Oct; 46(40):7513-5. PubMed ID: 20830418
[TBL] [Abstract][Full Text] [Related]
13. Mesoporous silica material TUD-1 as a drug delivery system.
Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
[TBL] [Abstract][Full Text] [Related]
14. Nanoporous polyelectrolyte spheres prepared by sequentially coating sacrificial mesoporous silica spheres.
Wang Y; Yu A; Caruso F
Angew Chem Int Ed Engl; 2005 May; 44(19):2888-92. PubMed ID: 15818632
[No Abstract] [Full Text] [Related]
15. Synthesis of hollow asymmetrical silica dumbbells with a movable inner core.
Nagao D; van Kats CM; Hayasaka K; Sugimoto M; Konno M; Imhof A; van Blaaderen A
Langmuir; 2010 Apr; 26(7):5208-12. PubMed ID: 20073531
[TBL] [Abstract][Full Text] [Related]
16. Controlled release using mesoporous materials containing gate-like scaffoldings.
Aznar E; Martínez-Máñez R; Sancenón F
Expert Opin Drug Deliv; 2009 Jun; 6(6):643-55. PubMed ID: 19519290
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous silica nanotubes coated with multilayered polyelectrolytes for pH-controlled drug release.
Yang YJ; Tao X; Hou Q; Ma Y; Chen XL; Chen JF
Acta Biomater; 2010 Aug; 6(8):3092-100. PubMed ID: 20197128
[TBL] [Abstract][Full Text] [Related]
18. Tailoring of multilayered core-shell nanostructure for multicomponent administration and controllable release of biologically active ions.
Gou Z; Weng W; Du P; Han G; Yan W
J Biomed Mater Res A; 2008 Jun; 85(4):909-18. PubMed ID: 17896764
[TBL] [Abstract][Full Text] [Related]
19. Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy.
Chen Y; Chen H; Guo L; He Q; Chen F; Zhou J; Feng J; Shi J
ACS Nano; 2010 Jan; 4(1):529-39. PubMed ID: 20041633
[TBL] [Abstract][Full Text] [Related]
20. Combination of adsorption by porous CaCO3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug delivery.
Wang C; He C; Tong Z; Liu X; Ren B; Zeng F
Int J Pharm; 2006 Feb; 308(1-2):160-7. PubMed ID: 16359836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
